ZIM
UTHR icon

Zacks Investment Management’s United Therapeutics UTHR Stock Holding History

Zacks Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,457
Closed -$2.07M – 705
2022
Q4 		$2.07M Sell
7,457
-29
-0.4% -$7.32K 0.03% 273
2022
Q3 		$1.57M Buy
7,486
+93
+1% +$20.8K 0.03% 289
2022
Q2 		$1.74M Buy
+7,393
New +$1.5M 0.03% 273
2016
Q2 		– Sell
-2,327
Closed -$259K – 718
2016
Q1 		$259K Buy
+2,327
New +$294K 0.01% 522
2014
Q3 		– Sell
-5,237
Closed -$463K – 752
2014
Q2 		$463K Buy
5,237
+252
+5% +$24.2K 0.02% 460
2014
Q1 		$469K Buy
+4,985
New +$510K 0.02% 415

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return